Anticipated Cost Savings with Alternate Dosing Schema of Nivolumab/Ipilimumab for the Treatment of Metastatic Melanoma
Authors:
- Allison KupshAKAllison Kupsh
- Laura AlwanLALaura Alwan
- Eve SegalESEve Segal
- Kate TrieselmannKTKate Trieselmann
- Evan HallEHEvan Hall
- MdMDMd
- 15 August 2021
- journal article
- research article
- Published by HMP Communications, LLC in Journal of Clinical Pathways
- Vol. 7 (6)